Sohn Catherine A. 4
4 · Altimmune, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Sohn Catherine A.
Director
Transactions
- Award
Stock Options (option to buy)
2023-03-23+47,000→ 47,000 totalExercise: $4.19Exp: 2033-03-23→ Common Stock, par value $0.0001 (47,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following March 23, 2023, subject to the reporting person's continued service through the applicable vesting